Cellular Inhibitor of Apoptosis 1 (cIAP-1) Degradation by Caspase 8 During TNF-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis

Overview

Journal Exp Cell Res

Specialty Cell Biology

Date 2010 Oct 19

PMID 20951133

Citations 23

Authors

Maria Eugenia Guicciardi

Justin L Mott

Steven F Bronk

Satoshi Kurita

Christian D Fingas

Gregory J Gores

Affiliations

Soon will be listed here.

Abstract

TNF-related apoptosis-inducing ligand (TRAIL) is a potential chemotherapeutic agent with high selectivity for malignant cells. Many tumors, however, are resistant to TRAIL cytotoxicity. Although cellular inhibitors of apoptosis 1 and 2 (cIAP-1 and -2) are often over-expressed in cancers, their role in mediating TRAIL resistance remains unclear. Here, we demonstrate that TRAIL-induced apoptosis of liver cancer cells is associated with degradation of cIAP-1 and X-linked IAP (XIAP), whereas cIAP-2 remains unchanged. Lower concentrations of TRAIL causing minimal or no apoptosis do not alter cIAP-1 or XIAP protein levels. Silencing of cIAP-1 expression, but not XIAP or cIAP-2, as well as co-treatment with a second mitochondrial activator of caspases (SMAC) mimetic (which results in rapid depletion of cIAP-1), sensitizes the cells to TRAIL. TRAIL-induced loss of cIAP-1 and XIAP requires caspase activity. In particular, caspase 8 knockdown stabilizes both cIAP-1 and XIAP, while caspase 9 knockdown prevents XIAP, but not cIAP-1 degradation. Cell-free experiments confirmed cIAP-1 is a substrate for caspase 8, with likely multiple cleavage sites. These results suggest that TRAIL-mediated apoptosis proceeds through caspase 8-dependent degradation of cIAP-1. Targeted depletion of cIAP-1 by SMAC mimetics in conjunction with TRAIL may be beneficial for the treatment of human hepatobiliary malignancies.

Citing Articles

Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer Compounds.

Al Subait A, Alghamdi R, Ali R, Alsharidah A, Huwaizi S, Alkhodier R Int J Mol Sci. 2025; 26(2).

PMID: 39859448 PMC: 11766124. DOI: 10.3390/ijms26020736.

Induction of Breast Cancer Cell Apoptosis by TRAIL and Smac Mimetics: Involvement of RIP1 and cFLIP.

Holmgren C, Sunstrom Thornberg E, Granqvist V, Larsson C Curr Issues Mol Biol. 2022; 44(10):4803-4821.

PMID: 36286042 PMC: 9600666. DOI: 10.3390/cimb44100327.

FBXO7 triggers caspase 8-mediated proteolysis of the transcription factor FOXO4 and exacerbates neuronal cytotoxicity.

Lee S, Jung S, Lee Y, Hyun M, Chung K J Biol Chem. 2021; 297(6):101426.

PMID: 34800438 PMC: 8665361. DOI: 10.1016/j.jbc.2021.101426.

Antileukemic Natural Product Induced Both Apoptotic and Pyroptotic Programmed Cell Death and Differentiation Effect.

Leu W, Chang H, Chen I, Guh J, Chan S Int J Mol Sci. 2021; 22(20).

PMID: 34681898 PMC: 8538678. DOI: 10.3390/ijms222011239.

Exogenous Introduction of Initiator and Executioner Caspases Results in Different Apoptotic Outcomes.

Anson F, Thayumanavan S, Hardy J JACS Au. 2021; 1(8):1240-1256.

PMID: 34467362 PMC: 8385707. DOI: 10.1021/jacsau.1c00261.

References

Verhagen A, Ekert P, Pakusch M, Silke J, Connolly L, Reid G . Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell. 2000; 102(1):43-53. DOI: 10.1016/s0092-8674(00)00009-x. View

Du C, Fang M, Li Y, Li L, Wang X . Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell. 2000; 102(1):33-42. DOI: 10.1016/s0092-8674(00)00008-8. View

ODonnell M, Legarda-Addison D, Skountzos P, Yeh W, Ting A . Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling. Curr Biol. 2007; 17(5):418-24. PMC: 1868513. DOI: 10.1016/j.cub.2007.01.027. View

Wee L, Tan T, Ranganathan S . SVM-based prediction of caspase substrate cleavage sites. BMC Bioinformatics. 2007; 7 Suppl 5:S14. PMC: 1764470. DOI: 10.1186/1471-2105-7-S5-S14. View

Guicciardi M, Bronk S, Werneburg N, Yin X, Gores G . Bid is upstream of lysosome-mediated caspase 2 activation in tumor necrosis factor alpha-induced hepatocyte apoptosis. Gastroenterology. 2005; 129(1):269-84. DOI: 10.1053/j.gastro.2005.05.022. View

Varfolomeev E, Goncharov T, Fedorova A, Dynek J, Zobel K, Deshayes K . c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. J Biol Chem. 2008; 283(36):24295-9. PMC: 3259840. DOI: 10.1074/jbc.C800128200. View

Bertrand M, Milutinovic S, Dickson K, Ho W, Boudreault A, Durkin J . cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell. 2008; 30(6):689-700. DOI: 10.1016/j.molcel.2008.05.014. View

Rothe M, Pan M, Henzel W, Ayres T, Goeddel D . The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell. 1995; 83(7):1243-52. DOI: 10.1016/0092-8674(95)90149-3. View

Li L, Thomas R, Suzuki H, De Brabander J, Wang X, Harran P . A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death. Science. 2004; 305(5689):1471-4. DOI: 10.1126/science.1098231. View

10.

Salvesen G, Dixit V . Caspase activation: the induced-proximity model. Proc Natl Acad Sci U S A. 1999; 96(20):10964-7. PMC: 34227. DOI: 10.1073/pnas.96.20.10964. View

11.

Csomos R, Brady G, Duckett C . Enhanced cytoprotective effects of the inhibitor of apoptosis protein cellular IAP1 through stabilization with TRAF2. J Biol Chem. 2009; 284(31):20531-9. PMC: 2742817. DOI: 10.1074/jbc.M109.029983. View

12.

Bockbrader K, Tan M, Sun Y . A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells. Oncogene. 2005; 24(49):7381-8. DOI: 10.1038/sj.onc.1208888. View

13.

Barreyro F, Kobayashi S, Bronk S, Werneburg N, Malhi H, Gores G . Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis. J Biol Chem. 2007; 282(37):27141-27154. DOI: 10.1074/jbc.M704391200. View

14.

Deveraux Q, Reed J . IAP family proteins--suppressors of apoptosis. Genes Dev. 1999; 13(3):239-52. DOI: 10.1101/gad.13.3.239. View

15.

Yang L, Cao Z, Yan H, Wood W . Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res. 2003; 63(20):6815-24. View

16.

Csomos R, Wright C, Galban S, Oetjen K, Duckett C . Two distinct signalling cascades target the NF-kappaB regulatory factor c-IAP1 for degradation. Biochem J. 2009; 420(1):83-91. PMC: 2677214. DOI: 10.1042/BJ20082140. View

17.

Varfolomeev E, Blankenship J, Wayson S, Fedorova A, Kayagaki N, Garg P . IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell. 2007; 131(4):669-81. DOI: 10.1016/j.cell.2007.10.030. View

18.

Vince J, Chau D, Callus B, Wong W, Hawkins C, Schneider P . TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. J Cell Biol. 2008; 182(1):171-84. PMC: 2447903. DOI: 10.1083/jcb.200801010. View

19.

Samuel T, Welsh K, Lober T, Togo S, Zapata J, Reed J . Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases. J Biol Chem. 2005; 281(2):1080-90. DOI: 10.1074/jbc.M509381200. View

20.

LeBlanc H, Ashkenazi A . Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ. 2003; 10(1):66-75. DOI: 10.1038/sj.cdd.4401187. View